Altamira Therapeutics News

Altamira Therapeutics | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

Apr 23 10:18

Altamira Therapeutics | EFFECT: Others

Apr 18 18:06

Altamira Therapeutics | 424B4: Prospectus

Apr 18 04:25

Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 17 05:01

Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 10 20:32

Altamira Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Apr 10 20:17

Altamira Therapeutics | F-1: Registration statement for securities of certain foreign private issuers

Apr 10 20:17

Altamira Therapeutics | 20-F: Registration statement / Annual report / Transition report

Apr 10 20:02

Altamira Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Thomas Meyer(1.2%)

Mar 13 23:08

Altamira Therapeutics | 424B4: Prospectus

Jan 22 13:00

Altamira Therapeutics | EFFECT: Others

Jan 22 13:00

Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Jan 19 13:00

Altamira Therapeutics | 424B5: Prospectus

Jan 19 13:00

Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

Jan 19 13:00

Altamira Therapeutics | CORRESP: CORRESP

Jan 18 00:41

Altamira Therapeutics | UPLOAD: Others

Jan 17 00:41

Altamira Therapeutics | F-3: Registration statement for specified transactions by certain foreign private issuers

Jan 8 13:00

Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 11, 2023 21:01

Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 11, 2023 21:00

Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 8, 2023 22:00